搜索临床试验以:Plasma kinetic vaporization
总计8041个结果
-
University Teaching Hospital Hall in TirolSalzburger Landeskliniken招聘中
-
Mansoura University未知
-
Nantes University Hospital招聘中
-
Assistance Publique Hopitaux De Marseille招聘中
-
Institut de Médecine et d'Epidémiologie Appliquée...完全的
-
Cairo UniversityTheodor Bilharz Research Institute完全的
-
Queen's University完全的不包括资本设备购买的直接成本 | 操作员(外科医生)完成的问卷调查 | 操作参数(时间、出血等) | 并发症(术后滞留、出血、再次入院、感染等) | 使用经过验证的症状评估工具进行 3 个月的疗效评估(与基线相比)(详见结果指标)加拿大
-
Olympus Corporation of the AmericasLoma Linda University; VA Greater Los Angeles Healthcare System终止
-
Washington University School of MedicineNational Institute of Neurological Disorders and Stroke (NINDS)完全的
-
Mondelēz International, Inc.Centre de Recherche en Nutrition Humaine Rhone-Alpe; Institut de Recherches Cliniques de Montreal 和其他合作者完全的
-
Hamilton Health Sciences CorporationGenentech, Inc.完全的
-
University Hospital, Linkoeping完全的
-
Assistance Publique Hopitaux De Marseille终止
-
Centre Hospitalier Universitaire Dijon终止Patients With Spontaneous Rupture of the Fetal Membranes法国
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo完全的
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo完全的
-
University of HelsinkiSamfundet Folkhälsan; Sigrid Jusélius Foundation完全的
-
Shenzhen Geno-Immune Medical InstituteThe No.2 Clinical Hospital of the Ministry of Health招聘中
-
Janssen Research & Development, LLC尚未招聘
-
The Third Affiliated Hospital of Guangzhou Medical...招聘中
-
Ontario Clinical Oncology Group (OCOG)Pfizer尚未招聘
-
Nantes University Hospital尚未招聘
-
Assistance Publique - Hôpitaux de ParisInstitut Pasteur招聘中
-
Kite, A Gilead CompanyArcellx, Inc.尚未招聘
-
Academisch Medisch Centrum - Universiteit van Amsterdam...FIOR & GENTZ尚未招聘
-
Jules Bordet InstituteRayzeBio, Inc.尚未招聘多发性骨髓瘤复发 | 难治性多发性骨髓瘤 | 多发性骨髓瘤进展比利时
-
The First Affiliated Hospital of Soochow University尚未招聘多发性骨髓瘤 | 初诊 | MRD | 高风险
-
University Hospital, Angers尚未招聘
-
Shanghai Changzheng HospitalCARsgen Therapeutics Co., Ltd.尚未招聘高风险新诊断多发性骨髓瘤 (HRNDMM)